154 related articles for article (PubMed ID: 3279421)
1. Transforming genes in chronic myelogenous leukemia.
Liu E; Hjelle B; Bishop JM
Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1952-6. PubMed ID: 3279421
[TBL] [Abstract][Full Text] [Related]
2. High frequency of RAS oncogene mutation in chronic myeloid leukemia patients with myeloblastoma.
Tanaka K; Takauchi K; Takechi M; Kyo T; Dohy H; Kamada N
Leuk Lymphoma; 1994 Apr; 13(3-4):317-22. PubMed ID: 8049652
[TBL] [Abstract][Full Text] [Related]
3. Absence of N-ras mutations in myeloid and lymphoid blast crisis of chronic myeloid leukemia.
Watzinger F; Gaiger A; Karlic H; Becher R; Pillwein K; Lion T
Cancer Res; 1994 Jul; 54(14):3934-8. PubMed ID: 8033117
[TBL] [Abstract][Full Text] [Related]
4. Oncogene activation in human myeloid leukemia.
Janssen JW; Steenvoorden AC; Collard JG; Nusse R
Cancer Res; 1985 Jul; 45(7):3262-7. PubMed ID: 3859367
[TBL] [Abstract][Full Text] [Related]
5. The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia.
Ahuja H; Bar-Eli M; Arlin Z; Advani S; Allen SL; Goldman J; Snyder D; Foti A; Cline M
J Clin Invest; 1991 Jun; 87(6):2042-7. PubMed ID: 2040694
[TBL] [Abstract][Full Text] [Related]
6. A hypothesis regarding the development of acute myeloid leukemia from preleukemic disorders. The role of protooncogenes.
Preisler HD
Cancer Genet Cytogenet; 1988 May; 32(1):133-42. PubMed ID: 3162703
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism of the human c-abl gene: relation to incidence and course of chronic myelogenous leukemia.
Daniel L; Ahmed CM; Bloodgood RS; Kidd JR; Castiglione CM; Duttagupta S; Lebowitz P
Oncogene; 1987 May; 1(2):193-200. PubMed ID: 2894000
[TBL] [Abstract][Full Text] [Related]
8. Retrospective analysis of ras gene activation in myeloid leukemic cells.
Lübbert M; Jonas D; Miller CW; Herrmann F; Mertelsmann R; McCormick F; Koeffler HP
Oncogene; 1990 Apr; 5(4):583-7. PubMed ID: 2183160
[TBL] [Abstract][Full Text] [Related]
9. Possible transforming activity of interferon regulatory factor 2 in tumorigenicity assay of NIH3T3 cells transfected with DNA from chronic myelogenous leukemia patients.
Futaki M; Inokuchi K; Hanawa H; Tanosaki S; Dan K; Nomura T
Leuk Res; 1996 Jul; 20(7):601-5. PubMed ID: 8795694
[TBL] [Abstract][Full Text] [Related]
10. Altered transcription of the c-abl oncogene in K-562 and other chronic myelogenous leukemia cells.
Collins SJ; Kubonishi I; Miyoshi I; Groudine MT
Science; 1984 Jul; 225(4657):72-4. PubMed ID: 6587568
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms in the evolution of chronic myelocytic leukemia.
Cline MJ; Jat PS; Foti A
Leuk Lymphoma; 1992 Jul; 7(4):283-7. PubMed ID: 1493427
[TBL] [Abstract][Full Text] [Related]
12. Ras oncogene mutations are rare late stage events in chronic myelogenous leukemia.
LeMaistre A; Lee MS; Talpaz M; Kantarjian HM; Freireich EJ; Deisseroth AB; Trujillo JM; Stass SA
Blood; 1989 Mar; 73(4):889-91. PubMed ID: 2645949
[TBL] [Abstract][Full Text] [Related]
13. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
Okabe M
Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066
[TBL] [Abstract][Full Text] [Related]
14. Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients.
Maxwell SA; Kurzrock R; Parsons SJ; Talpaz M; Gallick GE; Kloetzer WS; Arlinghaus RB; Kouttab NM; Keating MJ; Gutterman JU
Cancer Res; 1987 Mar; 47(6):1731-9. PubMed ID: 2434223
[TBL] [Abstract][Full Text] [Related]
15. Rearrangement and amplification of c-abl sequences in the human chronic myelogenous leukemia cell line K-562.
Collins SJ; Groudine MT
Proc Natl Acad Sci U S A; 1983 Aug; 80(15):4813-7. PubMed ID: 6308652
[TBL] [Abstract][Full Text] [Related]
16. Activated protooncogenes in human lung tumors from smokers.
Reynolds SH; Anna CK; Brown KC; Wiest JS; Beattie EJ; Pero RW; Iglehart JD; Anderson MW
Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1085-9. PubMed ID: 1996309
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity in expression of the bcr-abl fusion transcript in CML blast crisis.
Andrews DF; Collins SJ
Leukemia; 1987 Oct; 1(10):718-24. PubMed ID: 3312834
[TBL] [Abstract][Full Text] [Related]
18. RAS gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes.
Janssen JW; Steenvoorden AC; Lyons J; Anger B; Böhlke JU; Bos JL; Seliger H; Bartram CR
Proc Natl Acad Sci U S A; 1987 Dec; 84(24):9228-32. PubMed ID: 3122217
[TBL] [Abstract][Full Text] [Related]
19. Transposition of the oncogene c-ets-1 in a t(11;19)(q23;p13) cell line transient during clonal evolution of blast crisis chronic myeloid leukemia.
Morris CM; Whitham SE; Fitzgerald PH
Leukemia; 1988 Feb; 2(2):74-8. PubMed ID: 3422701
[TBL] [Abstract][Full Text] [Related]
20. Activation of protooncogenes in spontaneously occurring non-liver tumors from C57BL/6 x C3H F1 mice.
Candrian U; You M; Goodrow T; Maronpot RR; Reynolds SH; Anderson MW
Cancer Res; 1991 Feb; 51(4):1148-53. PubMed ID: 1997158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
